Literature DB >> 18715757

Genetic associations with schizophrenia: meta-analyses of 12 candidate genes.

Jiajun Shi1, Elliot S Gershon, Chunyu Liu.   

Abstract

Genetic association studies on schizophrenia (SZ) have been repeatedly performed over the last two decades, resulting in a consensus that results are generally inconsistent. This consensus has begun to change as a result of meta-analyses (e.g., [Glatt, S.J. and Jonsson, E.G., 2006. The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141, 149-154.]). The SchizophreniaGene database (http://www.schizophreniaforum.org/res/sczgene/default.asp) has been a leader in meta-analyses of SZ association data, by dynamically and comprehensively cataloging all public genetic association studies, and preparing meta-analyses of case-control data. There are 19 "top" candidate genes from these analyses (access on December 20, 2007), showing the highest effect sizes and nominally significant associations of at least one variant in the meta-analyses of all ethnic samples or of samples of Caucasian ancestry. We selected 40 polymorphisms in 12 selected "top" genes for additional meta-analyses, which had at least one familial association data. We found gene-wide (correction for the number of meta-analyses for each gene) significant allelic association evidence for seven genes in the combined samples. The odds ratios (ORs) of the associated minor risk alleles range from 1.072 to 1.121, for DRD4, MTHFR, PPP3CC and TP53. For protective allele associations, the ORs are between 0.842 and 0.886, for DAO, IL1B, and SLC6A4. In population-based sub-analyses, we found significant results in four genes in Asians (ORs between 1.084 and 1.309 for DRD4, GABRB2, PPP3CC, and TP53), and one gene in European (OR of 0.888 for SLC6A4). The association of rs1816072 of GABRB2 with SZ in Asians was significant (adjusted P=0.048 after correction for 80 tests). No significant heterogeneity between case-control and family-based study designs was detected in 35 out of 40 polymorphisms. Our results further support eight potential SZ candidate genes and suggest that family data can reasonably be included in the meta-analysis of genetic associations.

Entities:  

Mesh:

Year:  2008        PMID: 18715757      PMCID: PMC2562556          DOI: 10.1016/j.schres.2008.06.016

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  65 in total

1.  Genomic control for association studies.

Authors:  B Devlin; K Roeder
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

Review 2.  Calcineurin regulation of neuronal plasticity.

Authors:  Rachel D Groth; Robert L Dunbar; Paul G Mermelstein
Journal:  Biochem Biophys Res Commun       Date:  2003-11-28       Impact factor: 3.575

3.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

4.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

Review 5.  Candidate gene studies in the 21st century: meta-analysis, mediation, moderation.

Authors:  M R Munafò
Journal:  Genes Brain Behav       Date:  2006       Impact factor: 3.449

6.  The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia.

Authors:  H Ashdown; Y Dumont; M Ng; S Poole; P Boksa; G N Luheshi
Journal:  Mol Psychiatry       Date:  2006-01       Impact factor: 15.992

Review 7.  The role of serotonin in schizophrenia.

Authors:  N Iqbal; H M van Praag
Journal:  Eur Neuropsychopharmacol       Date:  1995       Impact factor: 4.600

Review 8.  The neurobiology of slow synaptic transmission.

Authors:  P Greengard
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

9.  A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia.

Authors:  Y Okuyama; H Ishiguro; M Toru; T Arinami
Journal:  Biochem Biophys Res Commun       Date:  1999-05-10       Impact factor: 3.575

Review 10.  A dopaminergic deficit hypothesis of schizophrenia: the path to discovery.

Authors:  Arvid Carlsson; Maria L Carlsson
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

View more
  66 in total

1.  Toxoplasma gondii and other risk factors for schizophrenia: an update.

Authors:  E Fuller Torrey; John J Bartko; Robert H Yolken
Journal:  Schizophr Bull       Date:  2012-03-23       Impact factor: 9.306

2.  Calcineurin Aγ is a Functional Phosphatase That Modulates Synaptic Vesicle Endocytosis.

Authors:  Jeffrey R Cottrell; Bing Li; Jae Won Kyung; Crystle J Ashford; James J Mann; Tamas L Horvath; Timothy A Ryan; Sung Hyun Kim; David J Gerber
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

Review 3.  GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.

Authors:  Erik I Charych; Feng Liu; Stephen J Moss; Nicholas J Brandon
Journal:  Neuropharmacology       Date:  2009-07-23       Impact factor: 5.250

4.  Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia.

Authors:  Colm M P O'Tuathaigh; Brian P Kirby; Paula M Moran; John L Waddington
Journal:  Schizophr Bull       Date:  2009-11-24       Impact factor: 9.306

5.  Comprehensive behavioral analysis of calcium/calmodulin-dependent protein kinase IV knockout mice.

Authors:  Keizo Takao; Koichi Tanda; Kenji Nakamura; Jiro Kasahara; Kazuki Nakao; Motoya Katsuki; Kazuo Nakanishi; Nobuyuki Yamasaki; Keiko Toyama; Minami Adachi; Masahiro Umeda; Tsutomu Araki; Kohji Fukunaga; Hisatake Kondo; Hiroyuki Sakagami; Tsuyoshi Miyakawa
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

6.  A systematic meta-analysis of the association of Neuregulin 1 (NRG1), D-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia.

Authors:  Vinita Jagannath; Miriam Gerstenberg; Christoph U Correll; Susanne Walitza; Edna Grünblatt
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

7.  TP53 Polymorphism Contributes to the Susceptibility to Bipolar Disorder but Not to Schizophrenia in the Chinese Han Population.

Authors:  Jialei Yang; Xulong Wu; Jiao Huang; Zhaoxia Chen; Guifeng Huang; Xiaojing Guo; Lulu Zhu; Li Su
Journal:  J Mol Neurosci       Date:  2019-05-05       Impact factor: 3.444

8.  Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study.

Authors:  Gregor Habl; Mathias Zink; Georg Petroianu; Manfred Bauer; Thomas Schneider-Axmann; Martina von Wilmsdorff; Peter Falkai; Fritz A Henn; Andrea Schmitt
Journal:  J Neural Transm (Vienna)       Date:  2009-10-13       Impact factor: 3.575

9.  Comprehensive behavioral phenotyping of ryanodine receptor type 3 (RyR3) knockout mice: decreased social contact duration in two social interaction tests.

Authors:  Naoki Matsuo; Koichi Tanda; Kazuo Nakanishi; Nobuyuki Yamasaki; Keiko Toyama; Keizo Takao; Hiroshi Takeshima; Tsuyoshi Miyakawa
Journal:  Front Behav Neurosci       Date:  2009-05-07       Impact factor: 3.558

10.  The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth.

Authors:  C A Ghiani; M Starcevic; I A Rodriguez-Fernandez; R Nazarian; V T Cheli; L N Chan; J S Malvar; J de Vellis; C Sabatti; E C Dell'Angelica
Journal:  Mol Psychiatry       Date:  2009-06-23       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.